Home > Insider Trading > Filing (0001062993-14-000451)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1098880	Intelgenx Technologies Corp.	IGXT	Pharmaceutical Preparations (2834)	870638336

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1381866	G Horst Zerbe	714 Main Road Hudson A8 JOP1H0		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock (Par Value $0.00001)	Disposition	2014-01-29	200,000	$0.92	495,964	No	4	S	Direct
Common Stock (Par Value $0.00001)	Disposition	2014-01-30	9,000	$0.93	486,964	No	4	S	Direct
Common Stock (Par Value $0.00001)	Disposition	2014-01-31	41,000	$0.93	445,964	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock (Par Value $0.00001)	4,238,680	Indirect	See footnote

Footnotes

In connection with the acquisition of IntelGenx in 2006, Horst Zerbe became our President, Chief Executive Officer and Director and acquired 4,709,643.5 exchangeable shares of our Canadian holding corporation 6544631Canada Inc., a Canadian special purpose corporation which wholly owns IntelGenx Corp. (the "Exchangeable Shares"). The Exchangeable Shares are exchangeable, on a one for one basis, into shares of common stock of IntelGenx Technologies Corp. at Horst Zerbe's discretion. As of today 470,964 exchangeable shares have been exchanged into common stock of IntelGenx Technologies Corp. Prior to exchanging the remaining Exchangeable Shares for shares of common stock, Horst Zerbe has the right to vote 4,238,679.5 shares of common stock which are currently held in trust on behalf of Horst Zerbe. The 4,709,643.5 shares of common stock have not been registered for resale at this time.